Sharekhan

Natural Capsules Ltd

Wed 11/06/2025,15:19:57 | NSE : NATCAPSUQ

₹ 237.49-5.24 (-2.16%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 237.00

Previous Close

₹ 242.73

Volume

4778

Mkt Cap ( Rs. Cr)

₹245.59

High

₹ 247.93

Low

₹ 230.00

52 Week High

₹ 274.75

52 Week Low

₹ 164.00

Book Value Per Share

₹ 225.87

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Natural Capsules Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

4 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Natural Capsules Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Natural Capsules - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    10 Jun 2025, 12:26PM Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith
  • Natural Capsules - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    4 Jun 2025, 6:45PM Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Audio recording
  • Natural Capsules - Copy of Newspaper Publication

    31 May 2025, 2:46PM Natural Capsules Limited has informed the Exchange about Copy of Newspaper Publication
  • Natural Capsules - Announcement under Regulation 30 (LODR)-Investor Presentation

    31 May 2025, 2:21PM Please find enclosed herewith the copy of investor presentation in connection with Audited Standalone & Consolidated Financial Results for the quarter
  • Natural Capsules - Investor Presentation

    31 May 2025, 2:16PM Natural Capsules Limited has informed the Exchange about Investor Presentation
  • Natural Capsules - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    30 May 2025, 4:11PM Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements)\r\nRegulations, 2015, we would like to
  • Natural Capsules - Analysts/Institutional Investor Meet/Con. Call Updates

    30 May 2025, 4:03PM Natural Capsules Limited has informed the Exchange about Schedule of meet
  • Natural Capsules - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    30 May 2025, 1:54PM NATURAL CAPSULES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Ag
  • Natural Capsules - Press Release

    30 May 2025, 7:51AM Natural Capsules Limited has informed the Exchange regarding a press release dated May 30, 2025, titled ""NATURAL CAPSULES LIMITED REPORTS Q4 & FY25 R
  • Natural Capsules - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    30 May 2025, 7:42AM Pursuant to Reg 30 of SEBI(LODR) Regulations,2015, Please find the enclosed herewith the copy of press release made to analysts and investors in conne
  • Natural Capsules - Outcome of Board Meeting

    29 May 2025, 9:27PM Natural Capsules Limited has informed the Exchange regarding Board meeting held on May 29, 2025.
  • Natural Capsules Q4 net profit jumps 55.62% at Rs 2.63 cr

    29 May 2025, 9:03PM The company reported standalone net profit of Rs 2.63 crore for the quarter ended March 31, 2025 as compared to Rs 1.69 crore in the same period last
  • Natural Capsules - Change in Management

    29 May 2025, 9:02PM Natural Capsules Limited has informed the Exchange about change in Management
  • Natural Capsules - Outcome of Board Meeting

    29 May 2025, 9:00PM Natural Capsules Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
  • Natural Capsules - Announcement under Regulation 30 (LODR)-Change in Management

    29 May 2025, 8:55PM This is to inform that the board of directors meeting held on Thursday,29th May 2025 have appointed directors, secretarial auditor, Internal auditor &
  • Natural Capsules - Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th May,2025

    29 May 2025, 8:50PM Outcome of Board Meeting held on Thursday, May 29\ 2025\r\n\r\nA. This is to inform that the Board of the Directors at their meeting held on Thursday,
  • Natural Capsules - Financial Results For The Quarter And Year Ended On 31St March,2025

    29 May 2025, 8:41PM This is to inform that the board of directors at their meeting held on Thursday, May 29th 2025 have approved the Audited standalone & consolidated fin
  • Natural Capsules - Board Meeting Intimation

    22 May 2025, 3:32PM NATURAL CAPSULES LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2025 to consider and approve the Yearly Audited Financial
  • Natural Capsules - Board Meeting Intimation for 166Th Meeting Of The Board Of Directors Of The Company Is Scheduled On Thursd

    22 May 2025, 4:31PM Natural Capsules Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and
  • Natural Capsules - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    7 May 2025, 3:26PM NATURAL CAPSULES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Ag
  • Natural Capsules - Resignation

    7 May 2025, 3:23PM Natural Capsules Limited has informed the Exchange regarding Resignation of Mrs Shilpa Burman as Company Secretary & Compliance Officer of the company
  • Natural Capsules - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

    7 May 2025, 1:59PM In compliance with provisions of Regulation 30 of LODR, we would like to inform that Mrs. Shilpa Burman has tendered resignation from the post of Comp
  • Natural Capsules - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

    2 May 2025, 3:53PM <b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'> <tr> <td><b>Sr
  • Natural Capsules - Disclosure under SEBI Takeover Regulations

    29 Apr 2025, 3:37PM Natural Capsules Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Subs
  • Natural Capsules - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    21 Apr 2025, 1:17PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
  • Natural Capsules has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    11 Apr 2025, 4:20PM As of March 2025, 51.21% is owned by Indian Promoters and 48.79% by Public. <p align=justify> Top five Promoters holding highest number of shares of N
  • Natural Capsules - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Apr 2025, 3:34PM Natural Capsules Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Natural Capsules - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Apr 2025, 3:27PM Pursuant to Regulation 74(5) of SEBI (DP) Regulations, 2018, we submit herewith certificate received from M/s Cameo Corporate Services Limited, RTA fo
  • Natural Capsules - Trading Window-XBRL

    27 Mar 2025, 3:48PM Natural Capsules Limited has informed the Exchange about Closure of Trading Window
  • Natural Capsules - Trading Window

    27 Mar 2025, 3:40PM Natural Capsules Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,

Key fundamentals

Evaluate the intrinsic value of Natural Capsules Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 221.3278 193.8159 173.2095 114.1357 71.7595
Liabilities 221.3278 193.8159 173.2095 114.1357 71.7595
Equity 10.3412 9.3318 9.2755 7.0118 6.2327
Gross Profit 19.2998 20.7658 35.4301 25.4914 10.9636
Net Profit 6.7111 7.805 19.1983 13.9539 6.947
Cash From Operating Activities 18.0288 5.3973 20.1067 5.0921 5.5485
NPM(%) 3.99 5.07 11.1 10.33 8.73
Revenue 167.9382 153.8063 172.868 135.065 79.5134
Expenses 148.6384 133.0405 137.4379 109.5736 68.5498
ROE(%) 2.87 3.34 8.21 5.97 2.97

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Natural Capsules Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 857.35 0.75 28.45 138.29 301.39 0.58
Lotus Eye Hospital and Institute Ltd 72.13 -1.85 206.09 503.89 3.55 0.00
Vaishali Pharma Ltd 12.89 0.16 214.83 259.73 3.13 0.00
Astec Lifesciences Ltd 808.20 -0.39 0.00 475.13 -687.10 0.00

Company Info

YEAR EVENTS 1993 - Natural Capsules Limited was incorporated as a Public Limited Copmany on 20th September with the Registrar of Companies, Karnataka at Bangalore. The company has obtained the Certificate of Commencement of business on the 19th January 1994. - The immediate objective of the company is to set up manufacturing facilities for manufacture of Empty Hard Gelatine Capsules with an installed capacity of 980 million Nos. per annum. 1995 - The Company has acquired land admeasuring 8165 sq. mtrs. from Karnataka Industrial Areas Development Board (KIADB) on lease cm sale basis. 1999 - The Company has set up facilities for manufacture of finished pharmaceutical formulations during the year. 2000 - The Company has entered into agreement with CDSL & NSDL for dematerialisation. 2003 - The company has started commercial production at its unit at Pondicherry. 2011 - The company have recommended dividend @12% on the equity shares of Rs. 10/- each. 2012 - The company have recommended dividend @15% on the equity shares of Rs. 10/- each. 2013 - The company have recommended dividend @15% on the equity shares of Rs. 10/- each. 2014 - The company have recommended dividend @15% on the equity shares of Rs. 10/- each. 2015 -Natural Capsules to acquire 40% shares from Supreem Pharmaceuticals Mysore Pvt Ltd. -Natural capsules adds exclusive manufacturing line for HPMC vegetarian capsules. -Natural Capsules to boost manufacturing capacity of Gelatin capsules at its Pondicherry unit. 2021 -The company issued rights shares of 1:2 at a premium of Rs. 90 per share. 2024 -The Company Commencement Of Commercial Production In High Speed HPMC Line.

YEAR EVENTS 1993 - Natural Capsules Limited was incorporated as a Public Limited Copmany on 20th September with the Registrar of Companies, Karnataka at Bangalore. The company has obtained the Certificate of Commencement of business on the 19th January 1994. - The immediate objective of the company is to set up manufacturing facilities for manufacture of Empty Hard Gelatine Capsules with an installed capacity of 980 million Nos. per annum. 1995 - The Company has acquired land admeasuring 8165 sq. mtrs. from Karnataka Industrial Areas Development Board (KIADB) on lease cm sale basis. 1999 - The Company has set up facilities for manufacture of finished pharmaceutical formulations during the year. 2000 - The Company has entered into agreement with CDSL & NSDL for dematerialisation. 2003 - The company has started commercial production at its unit at Pondicherry. 2011 - The company have recommended dividend @12% on the equity shares of Rs. 10/- each. 2012 - The company have recommended dividend @15% on the equity shares of Rs. 10/- each. 2013 - The company have recommended dividend @15% on the equity shares of Rs. 10/- each. 2014 - The company have recommended dividend @15% on the equity shares of Rs. 10/- each. 2015 -Natural Capsules to acquire 40% shares from Supreem Pharmaceuticals Mysore Pvt Ltd. -Natural capsules adds exclusive manufacturing line for HPMC vegetarian capsules. -Natural Capsules to boost manufacturing capacity of Gelatin capsules at its Pondicherry unit. 2021 -The company issued rights shares of 1:2 at a premium of Rs. 90 per share. 2024 -The Company Commencement Of Commercial Production In High Speed HPMC Line.

Read More

Parent Organisation

Natural Capsules Ltd.

Founded

20/09/1993

Managing Director

Mr.Sunil Laxminarayana Mundra

NSE Symbol

NATCAPSUQEQ

FAQ

The current price of Natural Capsules Ltd is ₹ 237.49.

The 52-week high for Natural Capsules Ltd is ₹ 247.93 and the 52-week low is ₹ 230.00.

The market capitalization of Natural Capsules Ltd is currently ₹ 245.59. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Natural Capsules Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Natural Capsules Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Natural Capsules Ltd shares.

The CEO of Natural Capsules Ltd is Mr.Sunil Laxminarayana Mundra, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT